AAP
23
3
KMX
47
3
STT
42
2
CNP
54
4
MLM
50
3
TXT
58
2
MAT
50
3
RSG
65
3
DD
53
4
ETR
68
3
XRX
52
4
VRTX
62
5
MS
55
7
UA
33
7
SIG
57
7
LRCX
52
6
WDC
49
3
QRVO
56
4
NWS
37
2
ADM
33
5
AAP
23
3
KMX
47
3
STT
42
2
CNP
54
4
MLM
50
3
TXT
58
2
MAT
50
3
RSG
65
3
DD
53
4
ETR
68
3
XRX
52
4
VRTX
62
5
MS
55
7
UA
33
7
SIG
57
7
LRCX
52
6
WDC
49
3
QRVO
56
4
NWS
37
2
ADM
33
5
Financhill
Back

Beam Therapeutics Quote, Financials, Valuation and Earnings

How Banks Can Seize Your Accounts

Learn More
Buy
54

BEAM
Beam Therapeutics

Last Price:
26.02
Seasonality Move:
33.43%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm

Beam Therapeutics Price Quote

$26.02
-0.28 (-1.06%)
(Updated: September 16, 2024 at 10:10 AM ET)

Beam Therapeutics Key Stats

Buy
54
Beam Therapeutics (BEAM) is a Buy
Day range:
$24.72 - $26.34
52-week range:
$16.95 - $49.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.04
P/B ratio:
2.54%
Volume:
943K
Avg. volume:
737.4K
1-year change:
5.07%
Market cap:
$2.2B
Revenue:
$377.7M
EPS:
$-1.81

How Much Does Beam Therapeutics Make?

Is Beam Therapeutics Growing As A Company?

  • What Is Beam Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.41%
  • What Is Beam Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Beam Therapeutics Stock Price Performance

What Is Beam Therapeutics 52-Week High & Low?

Beam Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Beam Therapeutics?

  • How Much Debt Does Beam Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Beam Therapeutics Have?
    Cash and short term investments quarterly total is $1B
  • What Is Beam Therapeutics’s Book Value Per Share?
    Book value per share is 10.37

Is Beam Therapeutics Cash Flow Positive?

  • What Is BEAM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$137.5M
  • What Is Beam Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $73.5M
  • What Is Beam Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $121.9M

Beam Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    BEAM return on invested capital is -16.48%
  • What Is Beam Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -10.63%
  • What Is BEAM Return On Equity?
    ROE is a measure of profitability and is -16.48%

Beam Therapeutics Earnings Date & Stock Price

Beam Therapeutics Competitors

  • Who Are Beam Therapeutics's Competitors?
    Below is a list of companies who compete with Beam Therapeutics or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • Myomo Inc (MYO)
    • Intellia Therapeutics Inc (NTLA)
    • Xtant Medical Holdings Inc (XTNT)

Beam Therapeutics Dividend Yield

Beam Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0.73%
Revenue: -41.48% -9.77%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 50.36
Upside from Last Price: 91.47%

Major Shareholders

  • How many BEAM shares are owned by institutional investors?
    114.3M BEAM shares are owned by institutional investors
  • How many BEAM shares are owned by insiders?
    1.5M BEAM shares are owned by insiders